ArticleNature communications2026
Volumetric 3D printing of a fluoropolymer and closed-loop chemical recycling of its fluorinated content.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Fluorinated polymers are indispensable in fields such as microfluidics, electronics, and biomedical engineering. Yet, their chemical stability leads to long-term environmental persistence, rendering end-of-life management essential. In parallel, their insolubility and lack of melt behavior complicate fabrication into complex geometries, restricting their use in 3D printing. Here, a fluorinated photoresist is introduced that enables tomographic volumetric 3D printing with closed-loop chemical recycling of its fluorinated content. The photoresist-based on an alkene-functionalized fluorinated diol and a multifunctional thiol-supports rapid fabrication of centimeter-scale objects with reproducible feature sizes down to 56μm, among the smallest reported to date. Selective urethane hydrolysis under alkaline conditions yields ~97% recovery of the fluorinated monomer. The recovered monomer is re-functionalized and reprinted without loss of print fidelity, thermal stability, or mechanical performance. Volumetric 3D printed parts are biocompatible in vitro, supporting potential biomedical use. This represents the first demonstration of high-resolution tomographic volumetric printing of a fluoropolymer with closed-loop chemical recycling of its fluorinated content.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.